Cargando…

Extra-criteria clinical manifestations of antiphospholipid antibody should not be ignored

Detalles Bibliográficos
Autores principales:	Huang, Can, Hu, Chaojun, Zhao, Jiuliang, Wang, Qian, Tian, Xinping, Li, Mengtao, Zeng, Xiaofeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9771157/ https://www.ncbi.nlm.nih.gov/pubmed/35838406 http://dx.doi.org/10.1097/CM9.0000000000002128

Ejemplares similares

Anti-β2GPI-domain I antibody is associated with extra-criteria manifestations in a large prospective antiphospholipid syndrome cohort in China
por: Zhou, Yangzhong, et al.
Publicado: (2023)

Prevalence and diagnostic value of non-criteria antiphospholipid antibodies for antiphospholipid syndrome in Chinese patients
por: Li, Siting, et al.
Publicado: (2023)

Immunoglobulin A Isotype of Antiphospholipid Antibodies Does Not Provide Added Value for the Diagnosis of Antiphospholipid Syndrome in a Chinese Population
por: Hu, Chaojun, et al.
Publicado: (2020)

Evaluation of the Diagnostic Value of Non-criteria Antibodies for Antiphospholipid Syndrome Patients in a Chinese Cohort
por: Hu, Chaojun, et al.
Publicado: (2021)

Serum Calprotectin as a Potential Predictor of Microvascular Manifestations in Patients with Antiphospholipid Syndrome
por: Zhao, Yuan, et al.
Publicado: (2023)

Detection of IgA Antiphospholipid Antibodies Does not Improve Thrombotic Antiphospholipid Syndrome Classification: A two-Center Study
por: Su, Zhenzhen, et al.
Publicado: (2022)

Comparison of Different Test Systems for the Detection of Antiphospholipid Antibodies in a Chinese Cohort
por: Hu, Chaojun, et al.
Publicado: (2021)

Clinical characteristics and prognosis of patients with antiphospholipid antibodies based on cluster analysis: an 8-year cohort study
por: Qi, Wanting, et al.
Publicado: (2022)

Recurrent Non-stroke Central Neurologic Manifestations in Primary Antiphospholipid Syndrome
por: You, Hanxiao, et al.
Publicado: (2022)

Early Initiation of Anticoagulation Improves the Long-Term Prognosis in Patients With Antiphospholipid Syndrome Associated Portal Vein Thrombosis
por: You, Hanxiao, et al.
Publicado: (2021)

Clinical efficacy of tacrolimus in systemic lupus erythematosus with various manifestations: a real-world study
por: Bai, Wei, et al.
Publicado: (2022)

Validation of three prediction models for thrombosis recurrence in antiphospholipid syndrome patients based on a prospective cohort
por: Zhao, Yuan, et al.
Publicado: (2023)

Should not airborne transmission be ignored in the 2022 monkeypox outbreak?
por: Saied, AbdulRahman A.
Publicado: (2022)

Presence of Extra-Criteria Antiphospholipid Antibodies Is an Independent Risk Factor for Ischemic Stroke
por: Naranjo, Laura, et al.
Publicado: (2021)

Takayasu Arteritis: Criteria for Surgical Intervention Should Not Be Ignored
por: Perera, A. H., et al.
Publicado: (2013)

Immune Thrombocytopenia Could be an Independent Clinical Phenotype of Antiphospholipid Syndrome: A Prospective Cohort Study
por: Shi, Yu, et al.
Publicado: (2023)

The Challenges and Future Perspective for the Management of Systemic Lupus Erythematosus in China: A Concise Annual Report of 2020
por: Tian, Xinping, et al.
Publicado: (2022)

RheumCloud App: A Novel Mobile Application for the Management of Rheumatic Diseases Patients in China
por: Huang, Can, et al.
Publicado: (2022)

Non-Criteria Manifestations of Juvenile Antiphospholipid Syndrome
por: Miyamae, Takako, et al.
Publicado: (2021)

Criteria and Non-Criteria Antiphospholipid Antibodies in Antiphospholipid Syndrome: How Strong Are They Correlated?
por: Caraiola, Simona, et al.
Publicado: (2023)

Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19
por: Zhang, Yan, et al.
Publicado: (2020)

Sex Differences in Clinical Characteristics and Prognosis in Primary Thrombotic Antiphospholipid Syndrome
por: Huang, Yongfa, et al.
Publicado: (2022)

Pediatric Ventilator Liberation Guideline: Should the T-Piece and Automatic Tube Compensation Be Ignored in the Spontaneous Breathing Trial?
por: Havan, Merve, et al.
Publicado: (2023)

Non-criteria antiphospholipid antibodies in antiphospholipid syndrome: Diagnostic value added
por: Liu, Xiangjun, et al.
Publicado: (2022)

Chinese SLE Treatment and Research Group (CSTAR) Registry 2009–2019: Major Clinical Characteristics of Chinese Patients with Systemic Lupus Erythematosus
por: Li, Mengtao, et al.
Publicado: (2021)

2022 Chinese guideline for the management of pregnancy and reproduction in systemic lupus erythematosus
por: Tian, Xinping, et al.
Publicado: (2023)

The efficacy of Mycophenolate mofetil for the treatment of Chinese Takayasu’s arteritis
por: Li, Jing, et al.
Publicado: (2016)

Anti-SmD1 antibodies are associated with renal disorder, seizures, and pulmonary arterial hypertension in Chinese patients with active SLE
por: Hu, Chaojun, et al.
Publicado: (2017)

Impact of pregnancy in patients with systemic lupus erythematosus-associated pulmonary arterial hypertension: case series and literature review
por: Li, Mucong, et al.
Publicado: (2022)

Efficacy and safety of immunosuppressive agents for adults with lupus nephritis: a systematic review and network meta-analysis
por: Jiang, Nan, et al.
Publicado: (2023)

Cause of death in Chinese Takayasu arteritis patients
por: Li, Jing, et al.
Publicado: (2016)

Safety and tolerability of mRNA COVID-19 vaccines in people with antiphospholipid antibodies
por: Sciascia, Savino, et al.
Publicado: (2021)

Mental Health in the Millennium Development Goals: Not Ignored
por: Sachs, Sonia Ehrlich, et al.
Publicado: (2007)

Criteria and Non-Criteria Antiphospholipid Antibodies and Cancer in Patients with Involuntary Weight Loss
por: Caraiola, Simona, et al.
Publicado: (2023)

“Non-criteria” antiphospholipid antibodies add value to antiphospholipid syndrome diagnoses in a large Chinese cohort
por: Liu, Tingting, et al.
Publicado: (2020)

An adult patient of X-linked hypophosphatemia with joint manifestation mimicking spondylarthritis
por: Wang, Chuhan, et al.
Publicado: (2022)

No point in travel bans if countries with poor surveillance are ignored
por: Preiser, Wolfgang, et al.
Publicado: (2022)

IFN-γ, should not be ignored in SLE
por: Liu, Wenping, et al.
Publicado: (2022)

Ocular manifestations of the antineutrophil cytoplasmic antibody and antiphospholipid syndromes
por: Khan, Sujoy
Publicado: (2013)

Neurological and Neuropsychiatric Manifestations of Antiphospholipid-Antibody Syndrome (APS)
por: Asif, Saba, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_k20ghlfa2kp29dgrav05p2v539